These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 8192705)

  • 41. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of colchicine on hepatic damage induced by carbon tetrachloride in rats].
    Vargas-Tank L; Carrión Y; de Marinis A; Larrañaga C; Ritter L
    Rev Med Chil; 1985 Apr; 113(4):291-5. PubMed ID: 3835636
    [No Abstract]   [Full Text] [Related]  

  • 43. Dehydroepiandrosterone restores hepatocellular function and prevents liver damage in estrogen-deficient females following trauma and hemorrhage.
    Kuebler JF; Jarrar D; Wang P; Bland KI; Chaudry IH
    J Surg Res; 2001 May; 97(2):196-201. PubMed ID: 11341799
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of portahepatic venous shunts and cirrhosis in carbon tetrachloride poisoning in rats.
    Hase T
    Am J Pathol; 1968 Jul; 53(1):83-98. PubMed ID: 5654526
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapeutic effects of octreotide on hepatofibrosis-induced with carbon tetrachloride in rats].
    Wang ZR; Li DG; Chen XM; Huang X; Wei HS; Wang YQ; Xu QF; Lu HM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Jul; 11(7):408-11. PubMed ID: 12890342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct measurement of hepatic indocyanine green clearance with near-infrared spectroscopy: separate evaluation of uptake and removal.
    Shinohara H; Tanaka A; Kitai T; Yanabu N; Inomoto T; Satoh S; Hatano E; Yamaoka Y; Hirao K
    Hepatology; 1996 Jan; 23(1):137-44. PubMed ID: 8550033
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Indocyanine green disappearance enhanced by prostaglandin E1 in patients with hepatic resection.
    Tsukada K; Sakaguchi T; Aono T; Ishizuka D; Fujita N; Hatakeyama K
    J Surg Res; 1996 Nov; 66(1):64-8. PubMed ID: 8954833
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The absolute bioavailability and pharmacokinetics of butorphanol nasal spray in patients with hepatic impairment.
    Vachharajani NN; Shyu WC; Garnett WR; Morgenthien EA; Barbhaiya RH
    Clin Pharmacol Ther; 1996 Sep; 60(3):283-94. PubMed ID: 8841151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice.
    Irwin RD
    Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversal of chemical-induced liver fibrosis in Wistar rats by puerarin.
    Zhang S; Ji G; Liu J
    J Nutr Biochem; 2006 Jul; 17(7):485-91. PubMed ID: 16426832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory effect of leflunomide on hepatic fibrosis induced by CCl4 in rats.
    Yao HW; Li J; Chen JQ; Xu SY
    Acta Pharmacol Sin; 2004 Jul; 25(7):915-20. PubMed ID: 15210065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatic artery flow and propranolol metabolism in perfused cirrhotic rat liver.
    Le Couteur DG; Hickey H; Harvey PJ; Gready J; McLean AJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1553-8. PubMed ID: 10336552
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of sulfobromophthalein and indocyanine green clearances in the dog.
    Center SA; Bunch SE; Baldwin BH; Hornbuckle WE; Tennant BC
    Am J Vet Res; 1983 Apr; 44(4):722-6. PubMed ID: 6869972
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Changes in hepatic fibrosis induced by carbon tetrachloride, after previous administration of vitamin A].
    Chehter L; Mor MM; Silva MR; Barbosa VP; Vilela MP; Parise ER
    Rev Paul Med; 1988; 106(4):185-9. PubMed ID: 3256914
    [No Abstract]   [Full Text] [Related]  

  • 55. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT; Marigold JH; Thompson RP
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of splenectomy on chronic hepatic injury by carbon tetrachloride in albino rats.
    Chandra M; Maheshwari HB; Mittal S; Mittal MM
    Indian J Exp Biol; 1978 Mar; 16(3):312-5. PubMed ID: 680830
    [No Abstract]   [Full Text] [Related]  

  • 57. Development of an experimental model of liver cirrhosis in rabbits.
    Brandão CG; Ferreira HH; Piovesana H; Polimeno NC; Ferraz JG; de Nucci G; Pedrazzoli J
    Clin Exp Pharmacol Physiol; 2000 Dec; 27(12):987-90. PubMed ID: 11117235
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of phenobarbital on the restoration of impaired drug metabolism in carbon tetrachloride-induced liver damage.
    Vorne M
    Ann Med Exp Biol Fenn; 1971; 49(3):143-50. PubMed ID: 5133794
    [No Abstract]   [Full Text] [Related]  

  • 59. Pharmacokinetics of diaspirin cross-linked haemoglobin in a rat model of hepatic cirrhosis.
    Palaparthy R; Kastrissios H; Gulati A
    J Pharm Pharmacol; 2001 Feb; 53(2):179-85. PubMed ID: 11273013
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acetone potentiation of chronic liver injury induced by repetitive administration of carbon tetrachloride.
    Charbonneau M; Tuchweber B; Plaa GL
    Hepatology; 1986; 6(4):694-700. PubMed ID: 3733003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.